SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Donald Y.M. Leung, Mark Boguniewicz, Middleton's Allergy Essentials, 2017,

    CrossRef

  2. 2
    Saxon D Smith, Andrew Lee, Alex Blaszczynski, Gayle Fischer, Attitudes of Australian dermatologists to the use and safety of topical corticosteroids in paediatric atopic dermatitis, Australasian Journal of Dermatology, 2016, 57, 2
  3. 3
    Elena Galli, Iria Neri, Giampaolo Ricci, Ermanno Baldo, Maurizio Barone, Anna Belloni Fortina, Roberto Bernardini, Irene Berti, Carlo Caffarelli, Elisabetta Calamelli, Lucetta Capra, Rossella Carello, Francesca Cipriani, Pasquale Comberiati, Andrea Diociaiuti, Maya El Hachem, Elena Fontana, Michaela Gruber, Ellen Haddock, Nunzia Maiello, Paolo Meglio, Annalisa Patrizi, Diego Peroni, Dorella Scarponi, Ingrid Wielander, Lawrence F. Eichenfield, Consensus Conference on Clinical Management of pediatric Atopic Dermatitis, Italian Journal of Pediatrics, 2016, 42, 1

    CrossRef

  4. 4
    Wenyi Wang, Elaine Wat, Patrick C. L. Hui, Ben Chan, Frency S. F. Ng, Chi-Wai Kan, Xiaowen Wang, Huawen Hu, Eric C. W. Wong, Clara B. S. Lau, Ping-Chung Leung, Dual-functional transdermal drug delivery system with controllable drug loading based on thermosensitive poloxamer hydrogel for atopic dermatitis treatment, Scientific Reports, 2016, 6, 24112

    CrossRef

  5. 5
    Esther Roé Crespo, Eulàlia Baselga Torres, Objetivos y utilidad de las escuelas de atopia, Piel, 2016, 31, 1, 1

    CrossRef

  6. 6
    Saxon D Smith, Andrew Lee, Alex Blaszczynski, Gayle Fischer, Pharmacists' knowledge about use of topical corticosteroids in atopic dermatitis: Pre and post continuing professional development education, Australasian Journal of Dermatology, 2016, 57, 2
  7. 7
    Tatsuki Fukuie, Satoshi Hirakawa, Masami Narita, Ichiro Nomura, Kenji Matsumoto, Yoshiki Tokura, Yukihiro Ohya, Potential preventive effects of proactive therapy on sensitization in moderate to severe childhood atopic dermatitis: A randomized, investigator-blinded, controlled study, The Journal of Dermatology, 2016, 43, 5
  8. 8
    Mark Boguniewicz, Donald Y.M. Leung, Pediatric Allergy: Principles and Practice, 2016,

    CrossRef

  9. 9
    M. J. Finberg, G. L. Muntingh, C. E. J. van Rensburg, A comparison of the leaf gel extracts of Aloe ferox and Aloe vera in the topical treatment of atopic dermatitis in Balb/c mice, Inflammopharmacology, 2015, 23, 6, 337

    CrossRef

  10. 10
    Sara Spielman, Jennifer LeBovidge, Karol Timmons, Lynda Schneider, A Review of Multidisciplinary Interventions in Atopic Dermatitis, Journal of Clinical Medicine, 2015, 4, 5, 1156

    CrossRef

  11. You have free access to this content11
    Emma Mooney, Marius Rademaker, Rebecca Dailey, Ben S Daniel, Catherine Drummond, Gayle Fischer, Rachael Foster, Claire Grills, Anne Halbert, Sarah Hill, Emma King, Elizabeth Leins, Vanessa Morgan, Roderic J Phillips, John Relic, Michelle Rodrigues, Laura Scardamaglia, Saxon Smith, John Su, Orli Wargon, David Orchard, Adverse effects of topical corticosteroids in paediatric eczema: Australasian consensus statement, Australasian Journal of Dermatology, 2015, 56, 4
  12. 12
    Deepti Gupta, Atopic Dermatitis, Medical Clinics of North America, 2015, 99, 6, 1269

    CrossRef

  13. You have free access to this content13
    Hengameh Kasrae, Leila Amiri Farahani, Parsa Yousefi, Efficacy of topical application of human breast milk on atopic eczema healing among infants: a randomized clinical trial, International Journal of Dermatology, 2015, 54, 8
  14. 14
    Anna Sokolova, Saxon D Smith, Factors contributing to poor treatment outcomes in childhood atopic dermatitis, Australasian Journal of Dermatology, 2015, 56, 4
  15. 15
    Anne Le Rhun, Hélène Aubert Wastiaux, Leïla Moret, Laurent Misery, Nathalie Danou, Isabelle Aujoulat, Grégoire Lagger, Sébastien Barbarot, Fears regarding the use of topical corticosteroids in atopic dermatitis: looking at the coping strategies and the role of health care providers. A qualitative study, Education Thérapeutique du Patient - Therapeutic Patient Education, 2015, 7, 2, 20102

    CrossRef

  16. 16
    M. Tamakuwala, G. Stagni, Fingolimod Hydrochloride Gel for Dermatological Applications: Optimization of Formulation Strength and Effect of Colloidal Oatmeal (Aveeno®) as Penetration Enhancer, AAPS PharmSciTech, 2015,

    CrossRef

  17. 17
    Abraham Getachew Kelbore, Workalemahu Alemu, Ashenafi Shumye, Sefonias Getachew, Magnitude and associated factors of Atopic dermatitis among children in Ayder referral hospital, Mekelle, Ethiopia, BMC Dermatology, 2015, 15, 1

    CrossRef

  18. 18
    Muhammad Irfan Siddique, Haliza Katas, Mohd Cairul Iqbal Mohd Amin, Shiow-Fern Ng, Mohd Hanif Zulfakar, Fhataheya Buang, Adawiyah Jamil, Minimization of Local and Systemic Adverse Effects of Topical Glucocorticoids by Nanoencapsulation: In Vivo Safety of Hydrocortisone–Hydroxytyrosol Loaded Chitosan Nanoparticles, Journal of Pharmaceutical Sciences, 2015, 104, 12
  19. 19
    Thomas Luger, Mark Boguniewicz, Warner Carr, Michael Cork, Mette Deleuran, Lawrence Eichenfield, Philippe Eigenmann, Regina Fölster-Holst, Carlo Gelmetti, Harald Gollnick, Eckard Hamelmann, Adelaide A. Hebert, Antonella Muraro, Arnold P. Oranje, Amy S. Paller, Carle Paul, Luis Puig, Johannes Ring, Elaine Siegfried, Jonathan M. Spergel, Georg Stingl, Alain Taieb, Antonio Torrelo, Thomas Werfel, Ulrich Wahn, Pimecrolimus in atopic dermatitis: Consensus on safety and the need to allow use in infants, Pediatric Allergy and Immunology, 2015, 26, 4
  20. 20
    S. Takeuchi, J. Oba, H. Esaki, M. Furue, Pruritus of patients with atopic dermatitis in daily life and their experience of therapeutic effects: results of a web-based questionnaire survey, British Journal of Dermatology, 2015, 173, 1
  21. 21
    Susan Guthrie, Teresa Bienkowska-Gibbs, Catriona Manville, Alexandra Pollitt, Anne Kirtley, Steven Wooding, The impact of the National Institute for Health Research Health Technology Assessment programme, 2003–13: a multimethod evaluation, Health Technology Assessment, 2015, 19, 67, 1

    CrossRef

  22. 22
    Jin Yong Lee, Young Her, Chul Woo Kim, Sang Seok Kim, Topical Corticosteroid Phobia among Parents of Children with Atopic Eczema in Korea, Annals of Dermatology, 2015, 27, 5, 499

    CrossRef

  23. 23
    Shiow-Fern Ng, Nurul-Asmaa Anuwi, Tengku-Noraisyah Tengku-Ahmad, Topical Lyogel Containing Corticosteroid Decreases IgE Expression and Enhances the Therapeutic Efficacy Against Atopic Eczema, AAPS PharmSciTech, 2015, 16, 3, 656

    CrossRef

  24. 24
    Deepani Munidasa, Antonia Lloyd-Lavery, Susan Burge, Tess McPherson, What Should General Practice Trainees Learn about Atopic Eczema?, Journal of Clinical Medicine, 2015, 4, 2, 360

    CrossRef

  25. 25
    Christine R. Totri, Lucia Diaz, Lawrence F. Eichenfield, 2014 update on atopic dermatitis in children, Current Opinion in Pediatrics, 2014, 26, 4, 466

    CrossRef

  26. 26
    Tali Czarnowicki, Rita V. Linkner, Mayte Suárez-Fariñas, Arie Ingber, Mark Lebwohl, An investigator-initiated, double-blind, vehicle-controlled pilot study: Assessment for tachyphylaxis to topically occluded halobetasol 0.05% ointment in the treatment of psoriasis, Journal of the American Academy of Dermatology, 2014, 71, 5, 954

    CrossRef

  27. 27
    Jee-Hee Hong, Hyun-A Jung, Clinical Efficacy of External Application Containing Betula platyphyllae Cortex, Viticis Fructus, Agrimoniae herba in Atopic Dermatitis, The Journal of Korean Oriental Medical Ophthalmology and Otolaryngology and Dermatology, 2014, 27, 1, 1

    CrossRef

  28. 28
    Peter A. Lio, Margaret Lee, Jennifer LeBovidge, Karol G. Timmons, Lynda Schneider, Clinical Management of Atopic Dermatitis: Practical Highlights and Updates from the Atopic Dermatitis Practice Parameter 2012, The Journal of Allergy and Clinical Immunology: In Practice, 2014, 2, 4, 361

    CrossRef

  29. 29
    Seung Bae Park, Myung Im, Young Lee, Jeung Hoon Lee, Jeongheui Lim, Yong-Ha Park, Young Joon Seo, Effect of Emollients Containing Vegetable-DerivedLactobacillusin the Treatment of Atopic Dermatitis Symptoms: Split-Body Clinical Trial, Annals of Dermatology, 2014, 26, 2, 150

    CrossRef

  30. 30
    Lawrence F. Eichenfield, Wynnis L. Tom, Timothy G. Berger, Alfons Krol, Amy S. Paller, Kathryn Schwarzenberger, James N. Bergman, Sarah L. Chamlin, David E. Cohen, Kevin D. Cooper, Kelly M. Cordoro, Dawn M. Davis, Steven R. Feldman, Jon M. Hanifin, David J. Margolis, Robert A. Silverman, Eric L. Simpson, Hywel C. Williams, Craig A. Elmets, Julie Block, Christopher G. Harrod, Wendy Smith Begolka, Robert Sidbury, Guidelines of care for the management of atopic dermatitis, Journal of the American Academy of Dermatology, 2014, 71, 1, 116

    CrossRef

  31. You have free access to this content31
    L.F. Eichenfield, C. Totri, Optimizing outcomes for paediatric atopic dermatitis, British Journal of Dermatology, 2014, 170,
  32. 32
    Els Mehuys, Philippe Gevaert, Guy Brusselle, Thierry Van Hees, Els Adriaens, Thierry Christiaens, Luc Van Bortel, Inge Van Tongelen, Jean-Paul Remon, Koen Boussery, Self-Medication in Persistent Rhinitis: Overuse of Decongestants in Half of the Patients, The Journal of Allergy and Clinical Immunology: In Practice, 2014, 2, 3, 313

    CrossRef

  33. 33
    Kyle B. Bartlett, Scott A. Davis, Steven R. Feldman, Topical antimicrobial acne treatment tolerability: A meaningful factor in treatment adherence?, Journal of the American Academy of Dermatology, 2014, 71, 3, 581

    CrossRef

  34. 34
    Na-Ra Han, Phil-Dong Moon, Hyung-Min Kim, Hyun-Ja Jeong, Tryptanthrin ameliorates atopic dermatitis through down-regulation of TSLP, Archives of Biochemistry and Biophysics, 2014, 542, 14

    CrossRef

  35. 35
    Laura Sandoval, Steven Feldman, Mild to Moderate Psoriasis, Third Edition, 2014,

    CrossRef

  36. 36
    Shiarra Stewart, Suzanne Pasmans, Marjolein de Bruin-Weller, Dermatocorticosteroïden bij constitutioneel eczeem, Huisarts en wetenschap, 2013, 56, 7, 346

    CrossRef

  37. 37
    Masaki Futamura, Ikuyo Masuko, Keiichi Hayashi, Yukihiro Ohya, Komei Ito, Effects of a Short-Term Parental Education Program on Childhood Atopic Dermatitis: A Randomized Controlled Trial, Pediatric Dermatology, 2013, 30, 4
  38. 38
    Reiji Kojima, Takeo Fujiwara, Akio Matsuda, Masami Narita, Osamu Matsubara, Shigeaki Nonoyama, Yukihiro Ohya, Hirohisa Saito, Kenji Matsumoto, Factors Associated with Steroid Phobia in Caregivers of Children with Atopic Dermatitis, Pediatric Dermatology, 2013, 30, 1
  39. 39
    Tsukasa Ishida, Shin Nishiumi, Toshihito Tanahashi, Akifumi Yamasaki, Asahi Yamazaki, Takahiro Akashi, Ikuya Miki, Yasuyuki Kondo, Jun Inoue, Shoji Kawauchi, Takeshi Azuma, Masaru Yoshida, Shigeto Mizuno, Linoleoyl ethanolamide reduces lipopolysaccharide-induced inflammation in macrophages and ameliorates 2,4-dinitrofluorobenzene-induced contact dermatitis in mice, European Journal of Pharmacology, 2013, 699, 1-3, 6

    CrossRef

  40. 40
    Shreya Dixit, Jennifer Bradford, Gayle Fischer, Management of nonsexually acquired genital ulceration using oral and topical corticosteroids followed by doxycycline prophylaxis, Journal of the American Academy of Dermatology, 2013, 68, 5, 797

    CrossRef

  41. 41
    Miriam Santer, Hana Burgess, Lucy Yardley, Steven J. Ersser, Sue Lewis-Jones, Ingrid Muller, Catherine Hugh, Paul Little, Managing childhood eczema: qualitative study exploring carers' experiences of barriers and facilitators to treatment adherence, Journal of Advanced Nursing, 2013, 69, 11
  42. 42
    Sabrina L. Martin, Suzanne T. McGoey, Bruce F. Bebo, Steven R. Feldman, Patients' educational needs about topical treatments for psoriasis, Journal of the American Academy of Dermatology, 2013, 68, 6, e163

    CrossRef

  43. 43
    Sébastien Barbarot, Claire Bernier, Mette Deleuran, Linda Raeve, Lawrence Eichenfield, May El Hachem, Carlo Gelmetti, Uwe Gieler, Peter Lio, Danielle Marcoux, Marie-Anne Morren, Antonio Torrelo, Jean Francois Stalder, Therapeutic Patient Education in Children with Atopic Dermatitis: Position Paper on Objectives and Recommendations, Pediatric Dermatology, 2013, 30, 2
  44. 44
    Zhi Qiang YIN, Wei Ming ZHANG, Guo Xin SONG, Dan LUO, Retracted: Meta-analysis on the comparison between two topical calcineurin inhibitors in atopic dermatitis, The Journal of Dermatology, 2012, 39, 6
  45. 45
    B. Lebrun-Vignes, O. Chosidow, Dermocorticoides, EMC - Tratado de Medicina, 2012, 16, 2, 1

    CrossRef

  46. 46
    B. Lebrun-Vignes, O. Chosidow, Dermocorticoïdes, EMC - Traité de médecine AKOS, 2012, 7, 1, 1

    CrossRef

  47. 47
    M. S. Bruin Weller, A. C. Knulst, Y. Meijer, C. A. F. M. Bruijnzeel-Koomen, S. G. M. Pasmans, Evaluation of the child with atopic dermatitis, Clinical & Experimental Allergy, 2012, 42, 3
  48. 48
    Johanna M. Mandelin, Andris Rubins, Anita Remitz, Kristine Cirule, James Dickinson, Vincent Ho, Mika J. Mäkelä, Silvestrs Rubins, Sakari Reitamo, Nasrullah Undre, Long-term efficacy and tolerability of tacrolimus 0.03% ointment in infants: a two-year open-label study, International Journal of Dermatology, 2012, 51, 1
  49. 49
    H. Aubert, S. Barbarot, Non-adhésion et corticothérapie, Annales de Dermatologie et de Vénéréologie, 2012, 139, S7

    CrossRef

  50. 50
    Kam-Lun E. Hon, Ting Fan Leung, Ho Chung Yau, Thomas Chan, Paradoxical use of oral and topical steroids in steroid-phobic patients resorting to traditional Chinese medicines, World Journal of Pediatrics, 2012, 8, 3, 263

    CrossRef

  51. 51
    In-Hwa Choi, Sehyun Kim, YoungChul Kim, Younghee Yun, The Effect of TJ-15 Plus TJ-17 on Atopic Dermatitis: A Pilot Study Based on the Principle of Pattern Identification, The Journal of Alternative and Complementary Medicine, 2012, 18, 6, 576

    CrossRef

  52. 52
    Xi Tan, Steven R Feldman, Jongwha Chang, Rajesh Balkrishnan, Topical drug delivery systems in dermatology: a review of patient adherence issues, Expert Opinion on Drug Delivery, 2012, 9, 10, 1263

    CrossRef

  53. 53
    A. Svensson, C. Chambers, A. Gånemo, S.A. Mitchell, A systematic review of tacrolimus ointment compared with corticosteroids in the treatment of atopic dermatitis, Current Medical Research and Opinion, 2011, 27, 7, 1395

    CrossRef

  54. 54
    TA Luger, Balancing efficacy and safety in the management of atopic dermatitis: the role of methylprednisolone aceponate, Journal of the European Academy of Dermatology and Venereology, 2011, 25, 3
  55. 55
    Miki MOROI, Sahori UCHI, Kenjiro NAKAMURA, Saori SATO, Nobuyuki SHIMIZU, Mikio FUJII, Takehisa KUMAGAI, Mariko SAITO, Kimiko UCHIYAMA, Toshiyuki WATANABE, Hideyo YAMAGUCHI, Tetsuro YAMAMOTO, Satoshi TAKEUCHI, Masutaka FURUE, Beneficial effect of a diet containing heat-killed Lactobacillus paracasei K71 on adult type atopic dermatitis, The Journal of Dermatology, 2011, 38, 2
  56. 56
    Manjunatha Kalavala, Magdalene A. Dohil, Calcineurin Inhibitors in Pediatric Atopic Dermatitis, American Journal of Clinical Dermatology, 2011, 12, 1, 15

    CrossRef

  57. 57
    Allan B. Grossman, Clinical Evaluation of 35% Urea in a Water-Lipid–Based Foam Containing Lactic Acid for Treatment of Mild-to-Moderate Xerosis of the Foot, Journal of the American Podiatric Medical Association, 2011, 101, 2, 153

    CrossRef

  58. 58
    Masutaka Furue, Takahito Chiba, Satoshi Takeuchi, Current status of atopic dermatitis in Japan, Asia Pacific Allergy, 2011, 1, 2, 64

    CrossRef

  59. 59
    B. Lebrun-Vignes, O. Chosidow, Dermocorticoides, EMC - Dermatología, 2011, 45, 2, 1

    CrossRef

  60. 60
    B. Lebrun-Vignes, O. Chosidow, Dermocorticoïdes, EMC - Dermatologie, 2011, 6, 1, 1

    CrossRef

  61. 61
    Esther Hong, Saxon Smith, Gayle Fischer, Evaluation of the Atrophogenic Potential of Topical Corticosteroids in Pediatric Dermatology Patients, Pediatric Dermatology, 2011, 28, 4
  62. 62
    Yasura Tashiro, Akiko Oyabu, Yoshio Imura, Atsuko Uchida, Naoko Narita, Masaaki Narita, Morphological abnormalities of embryonic cranial nerves after in utero exposure to valproic acid: implications for the pathogenesis of autism with multiple developmental anomalies, International Journal of Developmental Neuroscience, 2011, 29, 4, 359

    CrossRef

  63. 63
    April W. Armstrong, Randie H. Kim, Nayla Z. Idriss, Larissa N. Larsen, Peter A. Lio, Online video improves clinical outcomes in adults with atopic dermatitis: A randomized controlled trial, Journal of the American Academy of Dermatology, 2011, 64, 3, 502

    CrossRef

  64. 64
    Hyun Jung Kim, Hyun Jung Park, Jae Nam Yun, Se Kyoo Jeong, Sung Ku Ahn, Seung Hun Lee, Pseudoceramide-Containing Physiological Lipid Mixture Reduces Adverse Effects of Topical Steroids, Allergy, Asthma and Immunology Research, 2011, 3, 2, 96

    CrossRef

  65. 65
    Fiorella Monti, Francesca Agostini, Francesca Gobbi, Erica Neri, Sandra Schianchi, Fabio Arcangeli, Quality of life measures in Italian children with atopic dermatitis and their families, Italian Journal of Pediatrics, 2011, 37, 1, 59

    CrossRef

  66. 66
    H. Aubert-Wastiaux, L. Moret, A. Le Rhun, A.M. Fontenoy, J.M. Nguyen, C. Leux, L. Misery, P. Young, M. Chastaing, N. Danou, P. Lombrail, F. Boralevi, J.P. Lacour, J. Mazereeuw-Hautier, J.-F. Stalder, S. Barbarot, Topical corticosteroid phobia in atopic dermatitis: a study of its nature, origins and frequency, British Journal of Dermatology, 2011, 165, 4
  67. 67
    Inge M. Haeck, Ton J. Rouwen, Linda Timmer-de Mik, Marjolein S. de Bruin-Weller, Carla A. Bruijnzeel-Koomen, Topical corticosteroids in atopic dermatitis and the risk of glaucoma and cataracts, Journal of the American Academy of Dermatology, 2011, 64, 2, 275

    CrossRef

  68. 68
    Doo Hyeon Lim, Minghua Li, Jung-A Seo, Kyung-Min Lim, Seung Wook Ham, A novel organogermanium protected atopic dermatitis induced by oxazolone, Bioorganic & Medicinal Chemistry Letters, 2010, 20, 14, 4032

    CrossRef

  69. 69
    Michael Meurer, Lawrence F. Eichenfield, Vincent Ho, Paul C. Potter, Thomas Werfel, Thomas Hultsch, Addition of pimecrolimus cream 1% to a topical corticosteroid treatment regimen in paediatric patients with severe atopic dermatitis: A randomized, double-blind trial, Journal of Dermatological Treatment, 2010, 21, 3, 157

    CrossRef

  70. 70
    Eric L. Simpson, Atopic dermatitis: a review of topical treatment options, Current Medical Research and Opinion, 2010, 26, 3, 633

    CrossRef

  71. 71
    Rachel H. Foster, Gil Hardy, Raid G. Alany, Borage oil in the treatment of atopic dermatitis, Nutrition, 2010, 26, 7-8, 708

    CrossRef

  72. 72
    Yves Poulin, Kim Papp, Robert Bissonnette, Kirk Barber, Nabil Kerrouche, Hervé Villemagne, Clobetasol propionate shampoo 0.05% is efficacious and safe for long-term control of moderate scalp psoriasis, Journal of Dermatological Treatment, 2010, 21, 3, 185

    CrossRef

  73. 73
    Saxon D Smith, Esther Hong, Samantha Fearns, Alex Blaszczynski, Gayle Fischer, Corticosteroid phobia and other confounders in the treatment of childhood atopic dermatitis explored using parent focus groups, Australasian Journal of Dermatology, 2010, 51, 3
  74. 74
    Hiromi Kobayashi, Masamitsu Ishii, Satoshi Takeuchi, Yoichi Tanaka, Takahiro Shintani, Atsushi Yamatodani, Tadashi Kusunoki, Masutaka Furue, Efficacy and Safety of a Traditional Herbal Medicine,Hochu-ekki-toin the Long-Term Management ofKikyo(Delicate Constitution) Patients with Atopic Dermatitis: A 6-Month, Multicenter, Double-Blind, Randomized, Placebo-Controlled Study, Evidence-Based Complementary and Alternative Medicine, 2010, 7, 3, 367

    CrossRef

  75. 75
    Peck Y. Ong, Mark Boguniewicz, Investigational and Unproven Therapies in Atopic Dermatitis, Immunology and Allergy Clinics of North America, 2010, 30, 3, 425

    CrossRef

  76. 76
    Leontien B. Van Der Aa, Hugo S.A. Heymans, Wim M.C. Van Aalderen, Aline B. Sprikkelman, Probiotics and prebiotics in atopic dermatitis: review of the theoretical background and clinical evidence, Pediatric Allergy and Immunology, 2010, 21, 2p2
  77. 77
    S.-G. Consoli, M. Chastaing, L. Misery, Psiquiatría y dermatología, EMC - Dermatología, 2010, 44, 2, 1

    CrossRef

  78. 78
    S.-G. Consoli, M. Chastaing, L. Misery, Psychiatrie et dermatologie, EMC - Dermatologie, 2010, 5, 1, 1

    CrossRef

  79. 79
    Sarah L. Chamlin, Mary-Margaret Chren, Quality-of-life Outcomes and Measurement in Childhood Atopic Dermatitis, Immunology and Allergy Clinics of North America, 2010, 30, 3, 281

    CrossRef

  80. 80
    Guler Balcı Alparslan, Sevgi Sun Kapucu, THE CHANGES AND DIFFICULTIES EXPERIENCED BY PATIENTS USING STEROIDS, Journal of Renal Care, 2010, 36, 2
  81. 81
    David Farhi, Alain Taïeb, Gérard Tilles, Daniel Wallach, The historical basis of a misconception leading to undertreating atopic dermatitis (eczema):facts and controversies, Clinics in Dermatology, 2010, 28, 1, 45

    CrossRef

  82. 82
    Alexandra D. McCollum, Aimee Paik, Lawrence F. Eichenfield, The Safety and Efficacy of Tacrolimus Ointment in Pediatric Patients with Atopic Dermatitis, Pediatric Dermatology, 2010, 27, 5
  83. 83
    D Thaci, C Chambers, M Sidhu, B Dorsch, B Ehlken, S Fuchs, Twice-weekly treatment with tacrolimus 0.03% ointment in children with atopic dermatitis: clinical efficacy and economic impact over 12 months, Journal of the European Academy of Dermatology and Venereology, 2010, 24, 9
  84. 84
    Sheng-Li Chen, Jun Yan, Feng-Shan Wang, Two topical calcineurin inhibitors for the treatment of atopic dermatitis in pediatric patients: A meta-analysis of randomized clinical trials, Journal of Dermatological Treatment, 2010, 21, 3, 144

    CrossRef

  85. 85
    Andreas Storm, Eva Benfeldt, Stig Ejdrup Andersen, Jørgen Andersen, Basic drug information given by physicians is deficient, and patients’ knowledge low, Journal of Dermatological Treatment, 2009, 20, 4, 190

    CrossRef

  86. 86
    H Schäcke, TM Zollner, WD Döcke, H Rehwinkel, S Jaroch, W Skuballa, R Neuhaus, E May, U Zügel, K Asadullah, Characterization of ZK 245186, a novel, selective glucocorticoid receptor agonist for the topical treatment of inflammatory skin diseases, British Journal of Pharmacology, 2009, 158, 4
  87. 87
    Bridgit V. Nolan, Steven R. Feldman, Dermatologic Medication Adherence, Dermatologic Clinics, 2009, 27, 2, 113

    CrossRef

  88. 88
    Magdalene A. Dohil, Elizabeth Alvarez-Connelly, Lawrence F. Eichenfield, Fluocinolone Acetonide 0.01% in Peanut Oil: Safety and Efficacy Data in the Treatment of Childhood Atopic Dermatitis in Infants as Young as 3 Months of Age, Pediatric Dermatology, 2009, 26, 3
  89. 89
    John R. Ingram, Julie A. Martin, Andrew Y. Finlay, Impact of Topical Calcineurin Inhibitors on Quality of Life in Patients with Atopic Dermatitis, American Journal of Clinical Dermatology, 2009, 10, 4, 229

    CrossRef

  90. 90
    Mikkel Noerreslet, Gregor B.E. Jemec, Janine M. Traulsen, Involuntary autonomy: Patients' perceptions of physicians, conventional medicines and risks in the management of atopic dermatitis, Social Science & Medicine, 2009, 69, 9, 1409

    CrossRef

  91. 91
    A. Anstey, Management of atopic dermatitis: nonadherence to topical therapies in treatment of skin disease and the use of calcineurin inhibitors in difficult eczema, British Journal of Dermatology, 2009, 161, 2
  92. 92
    Chisato HOSOKAWA, Satoshi TAKEUCHI, Masutaka FURUE, Severity scores, itch scores and plasma substance P levels in atopic dermatitis treated with standard topical therapy with oral olopatadine hydrochloride, The Journal of Dermatology, 2009, 36, 4
  93. 93
    Sakari Reitamo, Johanna Mandelin, Andris Rubins, Anita Remitz, Mika Mäkelä, Kristine Cirule, Silvestrs Rubins, Sanita Zigure, Vincent Ho, James Dickinson, Nasrullah Undre, The pharmacokinetics of tacrolimus after first and repeated dosing with 0.03% ointment in infants with atopic dermatitis, International Journal of Dermatology, 2009, 48, 4
  94. 94
    Mohammad Maged. Y. El-Batawy, Manal A.-W. Bosseila, Heba M. Mashaly, Vanessa Suzan G.A. Hafez, Topical calcineurin inhibitors in atopic dermatitis: A systematic review and meta-analysis, Journal of Dermatological Science, 2009, 54, 2, 76

    CrossRef

  95. 95
    Michiel W. van der Linden, Fernie J.A. Penning-van Beest, Tamar Nijsten, Ron M.C. Herings, Topical Corticosteroids and the Risk of Diabetes Mellitus, Drug Safety, 2009, 32, 6, 527

    CrossRef

  96. 96
    David Pariser, Topical Corticosteroids and Topical Calcineurin Inhibitors in the Treatment of Atopic Dermatitis: Focus on Percutaneous Absorption, American Journal of Therapeutics, 2009, 16, 3, 264

    CrossRef

  97. 97
    Lily P.H. Yang, Monique P. Curran, Topical Pimecrolimus, Pediatric Drugs, 2009, 11, 6, 407

    CrossRef

  98. 98
    Mark Boguniewicz, Atopic Dermatitis, Second Edition, 2009,

    CrossRef

  99. 99
    Mark Boguniewicz, Donald Y.M. Leung, Middleton's Allergy: Principles and Practice, 2009,

    CrossRef

  100. 100
    Mark Boguniewicz, Noreen Nicol, Kim Kelsay, Donald Y.M. Leung, A Multidisciplinary Approach to Evaluation and Treatment of Atopic Dermatitis, Seminars in Cutaneous Medicine and Surgery, 2008, 27, 2, 115

    CrossRef

  101. 101
    J Ring, A Abraham, C De Cuyper, K Kim, T Langeland, V Parra, P Pigatto, T Reunala, R Szczepanski, M Möhrenschlager, M Bräutigam, AB Rossi, E Meents-Kopecky, D Schneider, Control of atopic eczema with pimecrolimus cream 1% under daily practice conditions: results of a > 2000 patient study, Journal of the European Academy of Dermatology and Venereology, 2008, 22, 2
  102. 102
    Karlen E. Luthy, Neil E. Peterson, Joey Wilkinson, Cost-Efficient Treatment Options for Uninsured or Underinsured Patients For Five Common Conditions, The Journal for Nurse Practitioners, 2008, 4, 8, 577

    CrossRef

  103. 103
    A. Wollenberg, M.K. Sidhu, I. Odeyemi, B. Dorsch, R. Koehne-Volland, M. Schaff, B. Ehlken, K. Berger, Economic evaluation of maintenance treatment with tacrolimus 0·1% ointment in adults with moderate to severe atopic dermatitis, British Journal of Dermatology, 2008, 159, 6
  104. 104
    B Sigurgeirsson, V Ho, C Ferrándiz, K Andriano, A Grinienko, P Jimenez, Effectiveness and safety of a prevention-of-flare-progression strategy with pimecrolimus cream 1% in the management of paediatric atopic dermatitis, Journal of the European Academy of Dermatology and Venereology, 2008, 22, 11
  105. 105
    A. Bewley, Expert consensus: time for a change in the way we advise our patients to use topical corticosteroids, British Journal of Dermatology, 2008, 158, 5
  106. 106
    William Abramovits, Adelaide A. Hebert, Mark Boguniewicz, Steven E. Kempers, Eduardo Tschen, Michael T. Jarratt, Anne W. Lucky, Raymond L. Cornelison, Leonard J. Swinyer, Terry M. Jones, Patient-reported outcomes from a multicenter, randomized, vehicle-controlled clinical study of MAS063DP (Atopiclair™) in the management of mild-to-moderate atopic dermatitis in adults, Journal of Dermatological Treatment, 2008, 19, 6, 327

    CrossRef

  107. 107
    H. Gollnick, R. Kaufmann, D. Stough, H. Heikkila, K. Andriano, A. Grinienko, P. Jimenez, Pimecrolimus cream 1% in the long-term management of adult atopic dermatitis: prevention of flare progression. A randomized controlled trial, British Journal of Dermatology, 2008, 158, 5
  108. 108
    Steven R. Feldman, Elizabeth J. Horn, Rajesh Balkrishnan, Mohammad K. Basra, Andrew Y. Finlay, Dan McCoy, Alan Menter, Peter C.M. van de Kerkhof, Psoriasis: Improving adherence to topical therapy, Journal of the American Academy of Dermatology, 2008, 59, 6, 1009

    CrossRef

  109. 109
    Harald Gollnick, Thomas Luger, Siegfried Freytag, Matthias Bräutigam, StabiEL: Stabilization of skin condition with Elidel – a patients’ satisfaction observational study addressing the treatment, with pimecrolimus cream, of atopic dermatitis pretreated with topical corticosteroid, Journal of the European Academy of Dermatology and Venereology, 2008, 22, 11
  110. 110
    Richard G. B. Langley, Lawrence F. Eichenfield, Anne W. Lucky, Mark Boguniewicz, Nathalie Barbier, Robert Cherill, Sustained Efficacy and Safety of Pimecrolimus Cream 1% when Used Long-term (up to 26 Weeks) to Treat Children with Atopic Dermatitis, Pediatric Dermatology, 2008, 25, 3
  111. 111
    Ekkehard May, Thomas Zollner, Heike Schäcke, Stefanie Schoepe, Hartmut Rehwinkel, Wolfram Sterry, Khusru Asadullah, Textbook of Atopic Dermatitis, 2008,

    CrossRef

  112. 112
    Jason Givan, Daniel Pearce, Steven Feldman, Mild-to-Moderate Psoriasis, Second Edition, 2008,

    CrossRef

  113. 113
    Mark Boguniewicz, Noreen Nicol, Textbook of Atopic Dermatitis, 2008,

    CrossRef

  114. 114
    Kristian Thestrup-Pedersen, Textbook of Atopic Dermatitis, 2008,

    CrossRef

  115. 115
    Richard G.B. Langley, Thomas A. Luger, Michael J. Cork, Dirk Schneider, Carle Paul, An Update on the Safety and Tolerability of Pimecrolimus Cream 1%: Evidence from Clinical Trials and Post-Marketing Surveillance, Dermatology, 2007, 215, 1, 27

    CrossRef

  116. 116
    Susan Tofte, Atopic Dermatitis, Nursing Clinics of North America, 2007, 42, 3, 407

    CrossRef

  117. 117
    Lawrence F. Eichenfield, Diamant Thaci, Yves de Prost, Lluis Puig, Carle Paul, Clinical Management of Atopic Eczema with Pimecrolimus Cream 1% (Elidel®) in Paediatric Patients, Dermatology, 2007, 215, 1, 3

    CrossRef

  118. 118
    B. Lebrun-Vignes, O. Chosidow, Corticoterapia local cutánea, EMC - Pediatría, 2007, 42, 2, 1

    CrossRef

  119. 119
    B. Lebrun-Vignes, O. Chosidow, Corticothérapie locale cutanée, EMC - Pédiatrie - Maladies infectieuses, 2007, 2, 1, 1

    CrossRef

  120. 120
    Lena Ring, Åsa Kettis-lindblad, Karin I. Kjellgren, Ylva Kindell, Marianne Maroti, Jörgen Serup, Living with skin diseases and topical treatment: Patients' and providers' perspectives and priorities, Journal of Dermatological Treatment, 2007, 18, 4, 209

    CrossRef

  121. 121
    C. Paul, Quoi de neuf en thérapeutique ?, Annales de Dermatologie et de Vénéréologie, 2007, 134, 8S64

    CrossRef

  122. 122
    Josefine Gradman, Ole D Wolthers, Short-term growth in children with eczema during treatment with topical mometasone furoate and tacrolimus, Acta Paediatrica, 2007, 96, 8
  123. 123
    Michael Meurer, Jann Lübbe, Alexander Kapp, Dirk Schneider, The Role of Pimecrolimus Cream 1% (Elidel®) in Managing Adult Atopic Eczema, Dermatology, 2007, 215, 1, 18

    CrossRef

  124. 124
    Gérard Tilles, Daniel Wallach, Alain Taïeb, Topical therapy of atopic dermatitis: Controversies from Hippocrates to topical immunomodulators, Journal of the American Academy of Dermatology, 2007, 56, 2, 295

    CrossRef

  125. 125
    M. Pitt, R. Garside, K. Stein, A cost-utility analysis of pimecrolimus vs. topical corticosteroids and emollients for the treatment of mild and moderate atopic eczema, British Journal of Dermatology, 2006, 154, 6
  126. 126
    Kafele T. Hodari, Jaleema R. Nanton, Christie L. Carroll, Steven R. Feldman, Rajesh Balkrishnan, Adherence in dermatology: A review of the last 20 years, Journal of Dermatological Treatment, 2006, 17, 3, 136

    CrossRef

  127. 127
    Ulrich R. Hengge, Thomas Ruzicka, Robert A. Schwartz, Michael J. Cork, Adverse effects of topical glucocorticosteroids, Journal of the American Academy of Dermatology, 2006, 54, 1, 1

    CrossRef

  128. 128
    Eric L. Simpson, Jon M. Hanifin, Atopic Dermatitis, Medical Clinics of North America, 2006, 90, 1, 149

    CrossRef

  129. 129
    Ryan Kirkland, Daniel J. Pearce, Rajesh Balkrishnan, Steven R. Feldman, Critical factors determining the potency of topical corticosteroids, Journal of Dermatological Treatment, 2006, 17, 3, 133

    CrossRef

  130. 130
    Katherine K. Brown, Wingfield E. Rehmus, Alexa B. Kimball, Determining the relative importance of patient motivations for nonadherence to topical corticosteroid therapy in psoriasis, Journal of the American Academy of Dermatology, 2006, 55, 4, 607

    CrossRef

  131. 131
    Tetsuya ANDO, Makoto HASHIRO, Keishi NODA, Jun ADACHI, Ritsuko HOSOYA, Ryoichi KAMIDE, Toshio ISHIKAWA, Gen KOMAKI, Development and validation of the psychosomatic scale for atopic dermatitis in adults, The Journal of Dermatology, 2006, 33, 7
  132. 132
    Ivy A Lee, Howard I Maibach, Pharmionics in Dermatology, American Journal of Clinical Dermatology, 2006, 7, 4, 231

    CrossRef

  133. 133
    Joseph F Fowler, Pimecrolimus, a topical calcineurin inhibitor for atopic dermatitis and other inflammatory skin diseases, Expert Review of Dermatology, 2006, 1, 3, 343

    CrossRef

  134. 134
    S. LEWIS-JONES, Quality of life and childhood atopic dermatitis: the misery of living with childhood eczema, International Journal of Clinical Practice, 2006, 60, 8
  135. 135
    Elaine Siegfried, Neil Korman, Carmen Molina, Farid Kianifard, Ken Abrams, Safety and efficacy of early intervention with pimecrolimus cream 1% combined with corticosteroids for major flares in infants and children with atopic dermatitis, Journal of Dermatological Treatment, 2006, 17, 3, 143

    CrossRef

  136. 136
    Jann L??bbe, Sheila F Friedlander, Bernard Cribier, Marie-Anne Morren, Amaro Garc??a-D??ez, Carlo Gelmetti, Heidelore Hofmann, Ronald H Houwing, Stephen Kownacki, Richard G B Langley, Marie Virtanen, Klaus Wolff, Steve Wisseh, Claire McGeown, Beatrice Abrams, Dirk Schneider, Safety, Efficacy, and Dosage of 1% Pimecrolimus Cream for the Treatment of Atopic Dermatitis in Daily Practice, American Journal of Clinical Dermatology, 2006, 7, 2, 121

    CrossRef

  137. 137
    S.E. Baron, P.K. Morris, L. Dye, D. Fielding, V. Goulden, The effect of dermatology consultations in secondary care on treatment outcome and quality of life in new adult patients with atopic dermatitis, British Journal of Dermatology, 2006, 154, 5
  138. 138
    Sarah L. Chamlin, The psychosocial burden of childhood atopic dermatitis, Dermatologic Therapy, 2006, 19, 2
  139. 139
    Masutaka Furue, Hiroshi Uchi, Yoichi Moroi, Sachiko Ogawa, Takeshi Nakahara, Kazunori Urabe, Topical tacrolimus in the management of atopic dermatitis in Japan, Dermatologic Therapy, 2006, 19, 2
  140. 140
    SP McKenna, D Whalley, Y Prost, D Staab, J Huels, CF Paul, D Assche, Treatment of paediatric atopic dermatitis with pimecrolimus (Elidel®, SDZ ASM 981): impact on quality of life and health-related quality of life, Journal of the European Academy of Dermatology and Venereology, 2006, 20, 3
  141. 141
    Jason Givan, Daniel Pearce, Steven Feldman, Mild-to-Moderate Psoriasis, 2006,

    CrossRef

  142. 142
    Tove Agner, 7. Compliance among patients with atopic eczema, Acta Dermato-Venereologica, 2005, 85, 0, 33

    CrossRef

  143. 143
    Mark Ling, Alice Gottlieb, David Pariser, Ivan Caro, Daniel Stewart, Graham Scott, Ken Abrams, A randomized study of the safety, absorption and efficacy of pimecrolimus cream 1% applied twice or four times daily in patients with atopic dermatitis, Journal of Dermatological Treatment, 2005, 16, 3, 142

    CrossRef

  144. 144
    M. Ribera-Pibernat, Análisis comparativo de la eficacia y la tolerancia de tacrolimus y pimecrolimus tópicos para el tratamiento de la dermatitis atópica, FMC - Formación Médica Continuada en Atención Primaria, 2005, 12, 10, 716

    CrossRef

  145. 145
    V. Niemeier, J. Kupfer, W. -B. Schill, U. Gieler, Atopic dermatitis – topical therapy: Do patients apply much too little?, Journal of Dermatological Treatment, 2005, 16, 2, 95

    CrossRef

  146. 146
    Miriam Lim Anderson, Atopic Dermatitis—More Than a Simple Skin Disorder, Journal of the American Academy of Nurse Practitioners, 2005, 17, 7
  147. 147
    Mark Boguniewicz, Atopic Dermatitis: Beyond the Itch that Rashes, Immunology and Allergy Clinics of North America, 2005, 25, 2, 333

    CrossRef

  148. 148
    James Del Rosso, Sheila Fallon Friedlander, Corticosteroids: Options in the era of steroid-sparing therapy, Journal of the American Academy of Dermatology, 2005, 53, 1, S50

    CrossRef

  149. 149
    G. Dagregorio, G. Guillet, Educational seminars for adults with atopic dermatitis: preliminary report about 103 patients, Allergy, 2005, 60, 4
  150. 150
    B. Ehlken, M. Möhrenschlager, B. Kugland, K. Berger, K. Quednau, J. Ring, Krankheitskostenstudie bei Patienten mit atopischem Ekzem in Deutschland, Der Hautarzt, 2005, 56, 12, 1144

    CrossRef

  151. 151
    Kim A. Papp, Thomas Werfel, Regina Fölster-Holst, Jean-Paul Ortonne, Paul C. Potter, Yves de Prost, Miles J. Davidson, Nathalie Barbier, Hans-Peter Goertz, Carle Paul, Long-term control of atopic dermatitis with pimecrolimus cream 1% in infants and young children: A two-year study, Journal of the American Academy of Dermatology, 2005, 52, 2, 240

    CrossRef

  152. 152
    Eli Gazala, Renata Sadka, Natalya Bilenko, Parents' Fears and Concerns Toward Inhaled Corticosteroid Treatment for Their Asthmatic Children, Pediatric Asthma, Allergy & Immunology, 2005, 18, 2, 82

    CrossRef

  153. 153
    Tien-Yi Tzung, Chyi-Bin Lin, Ya-Hui Chen, Chia-Yi Yang, Pimecrolimus and Narrowband UVB as Monotherapy or Combination Therapy in Children and Adolescents with Atopic Dermatitis, Acta Dermato-Venereologica, 2005, -1, 1, 1

    CrossRef

  154. 154
    S. Barbarot, A. Beauchet, S. Zaid, J.-P. Lacour, Prise en charge de la dermatite atopique de l’enfant par les dermatologues, pédiatres, médecins généralistes et allergologues : enquête nationale de pratique, Annales de Dermatologie et de Vénéréologie, 2005, 132, 283

    CrossRef

  155. 155
    C. Green, J.L. Colquitt, J. Kirby, P. Davidson, Topical corticosteroids for atopic eczema: clinical and cost effectiveness of once-daily vs. more frequent use, British Journal of Dermatology, 2005, 152, 1
  156. 156
    K.C. Bhol, P.J. Schechter, Topical nanocrystalline silver cream suppresses inflammatory cytokines and induces apoptosis of inflammatory cells in a murine model of allergic contact dermatitis, British Journal of Dermatology, 2005, 152, 6
  157. 157
    A.D. Ormerod, Topical tacrolimus and pimecrolimus and the risk of cancer: how much cause for concern?, British Journal of Dermatology, 2005, 153, 4
  158. 158
    F. Cambazard, Utilisation des dermocorticoïdes au cours de la dermatite atopique de l’enfant, Annales de Dermatologie et de Vénéréologie, 2005, 132, 64

    CrossRef

  159. 159
    Steven Kempers, Mark Boguniewicz, Eric Carter, Michael Jarratt, David Pariser, Dan Stewart, Matt Stiller, Eduardo Tschen, Katie Chon, Steve Wisseh, Beatrice Abrams, A randomized investigator-blinded study comparing pimecrolimus cream 1% with tacrolimus ointment 0.03% in the treatment of pediatric patients with moderate atopic dermatitis, Journal of the American Academy of Dermatology, 2004, 51, 4, 515

    CrossRef

  160. 160
    Tetsuo Shiohara, Jun Hayakawa, Yoshiko Mizukawa, Animal models for atopic dermatitis: are they relevant to human disease?, Journal of Dermatological Science, 2004, 36, 1, 1

    CrossRef

  161. 161
    B. Lebrun-Vignes, O. Chosidow, Dermocorticoïdes, Annales de Dermatologie et de Vénéréologie, 2004, 131, 1, 39

    CrossRef

  162. 162
    Masutaka Furue, Hiroshi Terao, Yoichi Moroi, Tetsuya Koga, Yumiko Kubota, Juichiro Nakayama, Fukumi Furukawa, Yoichi Tanaka, Ichiro Katayama, Naoko Kinukawa, Yoshiaki Nose, Kazunori Urabe, Dosage and Adverse Effects of Topical Tacrolimus and Steroids in Daily Management of Atopic Dermatitis, The Journal of Dermatology, 2004, 31, 4
  163. 163
    Kim Papp, Doris Staab, John Harper, Paul Potter, Lluis Puig, J.-P. Ortonne, Stephen Molloy, Nathalie Barbier, Carle Paul, Effect of pimecrolimus cream 1% on the long-term course of pediatric atopic dermatitis, International Journal of Dermatology, 2004, 43, 12
  164. 164
    J.R. Williams, M.L. Burr, H.C. Williams, Factors influencing atopic dermatitis—a questionnaire survey of schoolchildren's perceptions, British Journal of Dermatology, 2004, 150, 6
  165. 165
    Eduardo Fonseca Capdevila, Fobias y filias en el tratamiento con corticoides tópicos, Piel, 2004, 19, 8, 405

    CrossRef

  166. 166
    Jon M Hanifin, Kevin D Cooper, Vincent C Ho, Sewon Kang, Bernice R Krafchik, David J Margolis, Lawrence A Schachner, Robert Sidbury, Susan E Whitmore, Carol K Sieck, Abby S Van Voorhees, Guidelines of care for atopic dermatitis, Journal of the American Academy of Dermatology, 2004, 50, 3, 391

    CrossRef

  167. 167
    G. Guillet, L. Robcis, C. Herisse, M. Sarrasin, M. Delrez, M.H. Guillet, L’éducation des adultes atteints de dermatite atopique : Bilan d’une école de l’eczéma, Revue Française d'Allergologie et d'Immunologie Clinique, 2004, 44, 6, 563

    CrossRef

  168. 168
    TA Luger, M Lahfa, R Fölster-Holst, WP Gulliver, R Allen, S Molloy, N Barbier, C Paul, JD Bos, Long-term safety and tolerability of pimecrolimus cream 1% and topical corticosteroids in adults with moderate to severe atopic dermatitis, Journal of Dermatological Treatment, 2004, 15, 3, 169

    CrossRef

  169. 169
    Craig N. Burkhart, Craig G. Burkhart, Pilot study of patient satisfaction with nonfluorinated topical steroids compared with a topical immunomodulator in atopiform dermatitis, International Journal of Dermatology, 2004, 43, 3
  170. 170
    Keri Wellington, Stuart Noble, Pimecrolimus, American Journal of Clinical Dermatology, 2004, 5, 6, 479

    CrossRef

  171. 171
    Klaus Wolff, Anton Stuetz, Pimecrolimus for the treatment of inflammatory skin disease, Expert Opinion on Pharmacotherapy, 2004, 5, 3, 643

    CrossRef

  172. 172
    Carlos Ferrándiz, Cristina Mangas, Pimecrolimus. De los estudios al uso diario. Cuándo y cómo usarlo, Piel, 2004, 19, 3, 148

    CrossRef

  173. 173
    A. Alomar, J. Berth-Jones, J.D. Bos, A. Giannetti, S. Reitamo, T. Ruzicka, J-F. Stalder, K. Thestrup-Pedersen, The role of topical calcineurin inhibitors in atopic dermatitis:, British Journal of Dermatology, 2004, 151,
  174. 174
    Alexander M Marsland, Christopher EM Griffiths, Therapeutic potential of macrolide immunosuppressants in dermatology, Expert Opinion on Investigational Drugs, 2004, 13, 2, 125

    CrossRef

  175. 175
    Mark Boguniewicz, Topical treatment of atopic dermatitis, Immunology and Allergy Clinics of North America, 2004, 24, 4, 631

    CrossRef

  176. 176
    Peter Lucassen, Tussen allergieangst en corticosteroïdvrees, Huisarts en Wetenschap, 2004, 47, 8, 430

    CrossRef

  177. 177
    ME Kirkup, NM Birchall, EG Weinberg, K Helm, CTC Kennedy, Acute and maintenance treatment of atopic dermatitis in children – two comparative studies with fluticasone propionate (0.05%) cream, Journal of Dermatological Treatment, 2003, 14, 3, 141

    CrossRef

  178. 178
    PY Basak, M Ozturk, V Baysal, Assessment of information and education about topical corticosteroids in dermatology outpatient departments: experience from Turkey, Journal of the European Academy of Dermatology and Venereology, 2003, 17, 6
  179. 179
    M. Furue, H. Terao, W. Rikihisa, K. Urabe, N. Kinukawa, Y. Nose, T. Koga, Clinical dose and adverse effects of topical steroids in daily management of atopic dermatitis, British Journal of Dermatology, 2003, 148, 1
  180. 180
    Donald Rudikoff, Arash Akhavan, Steven R. Cohen, Color atlas: eczema, Clinics in Dermatology, 2003, 21, 2, 101

    CrossRef

  181. 181
    Andrew S. Kemp, Cost of Illness of Atopic Dermatitis in Children, PharmacoEconomics, 2003, 21, 2, 105

    CrossRef

  182. 182
    Lawrence F. Eichenfield, Lisa Beck, Elidel (pimecrolimus) cream 1%: A nonsteroidal topical agent for the treatment of atopic dermatitis, Journal of Allergy and Clinical Immunology, 2003, 111, 5, 1153

    CrossRef

  183. 183
    C. Ellis, T. Luger, D. Abeck, R. Allen, R.A.C. Graham-Brown, Y. De Prost, L.F. Eichenfield, C. Ferrandiz, A. Giannetti, J. Hanifin, J.Y.M. Koo, D. Leung, C. Lynde, J. Ring, R. Ruiz-Maldonado, J-H. Saurat, International Consensus Conference on Atopic Dermatitis II (ICCAD II): clinical update and current treatment strategies, British Journal of Dermatology, 2003, 148,
  184. 184
    Graham A Thom, Anne R Halbert, Paediatric atopic dermatitis in Perth general practice, Australasian Journal of Dermatology, 2003, 44, 1
  185. 185
    P. E. Beattie, M. S. Lewis-Jones, Parental knowledge of topical therapies in the treatment of childhood atopic dermatitis, Clinical and Experimental Dermatology, 2003, 28, 5
  186. 186
    Vincent C. Ho, Aditya Gupta, Roland Kaufmann, Gail Todd, Francisco Vanaclocha, Roberto Takaoka, Regina Fölster-Holst, Paul Potter, Katherine Marshall, Mark Thurston, Christopher Bush, Robert Cherill, Safety and efficacy of nonsteroid pimecrolimus cream 1% in the treatment of atopic dermatitis in infants, The Journal of Pediatrics, 2003, 142, 2, 155

    CrossRef

  187. 187
    Yoshifumi Inoue, Masakazu Isobe, Hideya Hayashi, The Combined Effect of Topical CX-659S, a Novel Diaminouracil Derivative, With Topical Corticosteroid on the Three Types of Allergic Responses in Mice or Guinea Pigs, Journal of Pharmacological Sciences, 2003, 91, 1, 71

    CrossRef

  188. 188
    Carolyn Charman, Hywel Williams, The use of corticosteroids and corticosteroid phobia in atopic dermatitis, Clinics in Dermatology, 2003, 21, 3, 193

    CrossRef

  189. 189
    Eulalia Baselga, Tratamiento de la dermatitis atópica en la infancia, Actas Dermo-Sifiliográficas, 2003, 94, 6, 345

    CrossRef

  190. 190
    Roman Schiffner, Julia Schiffner-Rohe, Michael Landthaler, Wilhelm Stolz, Treatment of Atopic Dermatitis and Impact on Quality of Life, PharmacoEconomics, 2003, 21, 3, 159

    CrossRef

  191. 191
    E.D. Baron, D. Barzilai, G. Johnston, M. Kawashima, M. Takigawa, H. Nakagawa, R.A.C. Graham-Brown, S.R. Stevens, Atopic dermatitis management: comparing the treatment patterns of dermatologists in Japan, U.S.A. and U.K., British Journal of Dermatology, 2002, 147, 4
  192. 192
    Mark Boguniewicz, Noreen Nicol, Conventional therapy for atopic dermatitis, Immunology and Allergy Clinics of North America, 2002, 22, 1, 107

    CrossRef

  193. 193
    J. Hanifin, A.K. Gupta, R. Rajagopalan, Intermittent dosing of fluticasone propionate cream for reducing the risk of relapse in atopic dermatitis patients, British Journal of Dermatology, 2002, 147, 3
  194. 194
    Alexander Kapp, Kim Papp, Ann Bingham, Regina Fölster-Holst, Jean-Paul Ortonne, Paul C. Potter, Wayne Gulliver, Carle Paul, Stephen Molloy, Nathalie Barbier, Mark Thurston, Yves de Prost, Long-term management of atopic dermatitis in infants with topical pimecrolimus, a nonsteroid anti-inflammatory drug, Journal of Allergy and Clinical Immunology, 2002, 110, 2, 277

    CrossRef

  195. 195
    T. Jung, New treatments for atopic dermatitis, Clinical & Experimental Allergy, 2002, 32, 3
  196. 196
    Bruce G Bender, Psychological dysfunction associated with atopic dermatitis, Immunology and Allergy Clinics of North America, 2002, 22, 1, 43

    CrossRef

  197. 197
    V. Niemeier, M. Nippesen, J. Kupfer, W-B. Schill, U. Gieler, Psychological factors associated with hand dermatoses: which subgroup needs additional psychological care?, British Journal of Dermatology, 2002, 146, 6
  198. 198
    B.Roger Allen, Tacrolimus ointment: Its place in the therapy of atopic dermatitis, Journal of Allergy and Clinical Immunology, 2002, 109, 3, 401

    CrossRef

  199. 199
    K. Thestrup-Pedersen, Treatment principles of atopic dermatitis, Journal of the European Academy of Dermatology and Venereology, 2002, 16, 1
  200. 200
    Mark Boguniewicz, Atopic Dermatitis, 2002,

    CrossRef

  201. 201
    Caroline Koblenzer, Atopic Dermatitis, 2002,

    CrossRef

  202. 202
    C.E.M. Griffiths, Ascomycin: an advance in the management of atopic dermatitis, British Journal of Dermatology, 2001, 144, 4
  203. 203
    Sharon S Raimer, The Safe Use of Topical Corticosteroids in Children, Pediatric Annals, 2001, 30, 4, 225

    CrossRef

  204. 204
    D.J. Eedy, What's new in atopic dermatitis?, British Journal of Dermatology, 2001, 145, 3, 380

    CrossRef

  205. 205
    D.J. Eedy, What's new in atopic dermatitis?, British Journal of Dermatology, 2001, 145, 3
  206. 206
    C. H. Smith, New approaches to topical therapy, Clinical and Experimental Dermatology, 2000, 25, 7
  207. 207
    P. S. Friedmann, M. R. Ardern-Jones, C. A. Holden, Atopic Dermatitis,
  208. 208
    Kim Thomas, Carolyn Charman, Helen Nankervis, Jane Ravenscroft, Hywel C. Williams, Atopic Eczema,
  209. 209
    Sherman Gu, Angela WH Yang, Charlie CL Xue, Chun G Li, Carmen Pang, Weiya Zhang, Hywel C Williams, Chinese herbal medicine for atopic eczema, The Cochrane Library,
  210. 210
    Sherman Gu, Carmen Pang, Charlie Changli Xue, Chun G Li, Angela WH Yang, Weiya Zhang, Hywel C Williams, Chinese herbal medicine for atopic eczema, The Cochrane Library,
  211. 211
    Elisa S. Gallo, Sarah L. Chamlin, Coping with the Burden of Chronic Skin Disease,
  212. 212
    Fiona J Bath-Hextall, Finola M Delamere, Rosemary Humphreys, Hywel C Williams, Weiya Zhang, Dietary supplements for established atopic eczema, The Cochrane Library,
  213. You have free access to this content213
    Esther J van Zuuren, Zbys Fedorowicz, Adriana Lavrijsen, Robin Christensen, Bernd Arents, Emollients and moisturisers for eczema, The Cochrane Library,
  214. 214
    A. Y. Finlay, C. H. Smith, General Aspects of Treatment,
  215. 215
    Helen Nankervis, Emma V Smith, Robert J Boyle, Lesley Rushton, Hywel C Williams, Deanne M Hewson, Thomas Platts-Mills, House dust mite reduction and avoidance measures for treating eczema, The Cochrane Library,
  216. 216
    Helen Nankervis, Emma V Pynn, Robert J Boyle, Lesley Rushton, Hywel C Williams, Deanne M Hewson, Thomas Platts-Mills, House dust mite reduction and avoidance measures for treating eczema, The Cochrane Library,
  217. 217
    Clive B. Archer, Immunopharmacological Mechanisms in Atopic Dermatitis,
  218. 218
    Gilli Lewis, Debbie Rickard, Infant with Infected Eczema,
  219. 219
    Katja Boehm, Max H Pittler, Niall Wilson, Christel van Gool, Rosemary Humphreys, Edzard Ernst, Oral evening primrose oil and borage oil for atopic eczema, The Cochrane Library,
  220. 220
    Joel TM Bamford, Sujoy Ray, Alfred Musekiwa, Christel van Gool, Rosemary Humphreys, Edzard Ernst, Oral evening primrose oil and borage oil for eczema, The Cochrane Library,
  221. 221
    DM Ashcroft, R Garside, K Stein, HC Williams, Topical pimecrolimus for atopic dermatitis, The Cochrane Library,
  222. 222
    Darren M Ashcroft, Li-Chia Chen, Ruth Garside, Ken Stein, Hywel C Williams, Topical pimecrolimus for eczema, The Cochrane Library,